Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
Liver Transpl. 2024 Jan 1;30(1):72-82. doi: 10.1097/LVT.0000000000000228. Epub 2023 Jul 26.
Recent deceased-donor allocation changes in the United States may have increased high-Model for End-Stage Liver Disease (MELD) living donor liver transplantation (LDLT); however, outcomes in these patients remain poorly defined. We aimed to examine the impact of the MELD score on LDLT outcomes. Using UNOS data (January 1, 2010-December 31, 2021), LDLT recipients were identified and stratified into low-MELD (<15), intermediate-MELD (15-24), and high-MELD (≥25) groups. We compared outcomes between MELD-stratified LDLT groups and between MELD-stratified LDLT and donation after brain death liver transplantation recipients. We used Kaplan-Meier analysis to compare graft survival rates and multivariable Cox proportional hazards modeling to identify factors associated with graft outcomes. Of 3558 LDLTs, 1605 (45.1%) were low-MELD, 1616 (45.4%) intermediate-MELD, and 337 (9.5%) high-MELD. Over the study period, the annual number of LDLTs increased from 282 to 569, and the proportion of high-MELD LDLTs increased from 3.9% to 7.7%. Graft survival was significantly higher in low-MELD versus high-MELD LDLT recipients (adjusted HR = 1.36, 95% CI: 1.03-1.79); however, 5-year survival exceeded 70.0% in both groups. We observed no significant difference in graft survival between high-MELD LDLT and high-MELD donation after brain death liver transplantation recipients (adjusted HR: 1.25, 95% CI:0.99-1.58), with a 5-year survival of 71.5% and 77.3%, respectively. Low LDLT center volume (<3 LDLTs/year) and recipient life support requirement were both associated with inferior graft outcomes among high-MELD LDLT recipients. While higher MELD scores confer graft failure risk in LDLT, high-MELD LDLT outcomes are acceptable with similar outcomes to MELD-stratified donation after brain death liver transplantation recipients. Future practice guidance should consider the expansion of LDLT recommendations to high-MELD recipients in centers with expertise to help reduce donor shortage.
最近美国的已故供者分配变化可能增加了高终末期肝病模型(MELD)评分的活体肝移植(LDLT);然而,这些患者的结局仍不清楚。我们旨在研究 MELD 评分对 LDLT 结局的影响。使用 UNOS 数据(2010 年 1 月 1 日-2021 年 12 月 31 日),确定 LDLT 受者并分为低 MELD(<15)、中 MELD(15-24)和高 MELD(≥25)组。我们比较了 MELD 分层 LDLT 组之间以及 MELD 分层 LDLT 组与脑死亡后肝移植受者之间的结局。我们使用 Kaplan-Meier 分析比较移植物存活率,并用多变量 Cox 比例风险模型确定与移植物结局相关的因素。在 3558 例 LDLT 中,1605 例(45.1%)为低 MELD,1616 例(45.4%)为中 MELD,337 例(9.5%)为高 MELD。在研究期间,LDLT 的年数量从 282 例增加到 569 例,高 MELD LDLT 的比例从 3.9%增加到 7.7%。低 MELD LDLT 受者的移植物存活率明显高于高 MELD LDLT 受者(调整 HR=1.36,95%CI:1.03-1.79);然而,两组的 5 年存活率均超过 70.0%。我们观察到高 MELD LDLT 受者与高 MELD 脑死亡后肝移植受者的移植物存活率之间没有显著差异(调整 HR:1.25,95%CI:0.99-1.58),5 年存活率分别为 71.5%和 77.3%。低 LDLT 中心容量(<3 例/LDLT 年)和受者生命支持需求均与高 MELD LDLT 受者的移植物不良结局相关。虽然较高的 MELD 评分会增加 LDLT 中的移植物失败风险,但高 MELD LDLT 的结局是可以接受的,与 MELD 分层脑死亡后肝移植受者的结局相似。未来的实践指南应考虑将 LDLT 建议扩大到有专业知识的中心的高 MELD 受者,以帮助减少供体短缺。